Altimmune (ALT) Tax Rate (2012 - 2025)
Altimmune's (ALT) quarterly Tax Rate came in at 31.03% in Q4 2025, down 1023.06% on a QoQ basis from 3.36% in Q1 2025.
Altimmune (ALT) Tax Rate (2012 - 2025) Analysis & Trends
Altimmune (ALT) has 11 years of Tax Rate data on file, last reported at 31.03% in Q4 2025.
- On a quarterly basis, Tax Rate changed N/A year-over-year to 31.03% in Q4 2025; TTM through Dec 2025 was 528.81%, a N/A change from a year earlier, with the FY2025 full-year figure at 528.81%, up 50781.0% from the prior year.
- Tax Rate for Q4 2025 stood at 31.03%, down from 3.36% in the prior quarter.
- Over the last five years, Tax Rate for ALT reached as high as 3.36% in Q1 2025 and fell as low as 31.03% in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -0.34 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 5.61 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 12.29 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 17.68 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 12.51 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -13.70 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Altimmune | 346.63 Mn | 346.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -31.03% |
| Dec 31, 2025 | -31.03% |
| Dec 31, 2025 | -31.03% |
| Mar 31, 2025 | 3.36% |
| Mar 31, 2025 | 3.36% |
| Mar 31, 2025 | 3.36% |
| Dec 31, 2022 | -1.52% |
| Dec 31, 2022 | -1.52% |
| Dec 31, 2022 | -1.52% |
| Sep 30, 2022 | 0.83% |
| Sep 30, 2022 | 0.83% |
| Sep 30, 2022 | 0.83% |
| Dec 31, 2020 | -42.82% |
| Dec 31, 2020 | -42.82% |
| Dec 31, 2020 | -42.82% |
| Sep 30, 2020 | 2.64% |
| Sep 30, 2020 | 2.64% |
| Sep 30, 2020 | 2.64% |
| Jun 30, 2020 | 8.61% |
| Jun 30, 2020 | 8.61% |